Saturday 17 October 2026
Export ALZN’s income statement to Excel — free account
Alzamend Neuro, Inc.
ALZN Healthcare Biotechnology
In the quarter to July 2026, EPS grew 46.9% and free cash flow grew 51.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.32
0.04
+3.13%
Follow ALZN
| Apr '26 | Apr '25 | Apr '24 | Apr '23 | Apr '22 | Apr '21 | Apr '20 | Dec '19 | Apr '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.31 | 6.58 | 0.14 | 2.03 | 12.37 | 3.24 | 1.83 | — | 1.27 | 1.27 |
Net Debt/EBITDA |
0.08 | 0.89 | 0.01 | 0.35 | 1.14 | 0.32 | 0.02 | 0.00 | 0.01 | 0.01 |
Debt/Assets |
0.00% | 0.00% | 47.61% | 0.00% | 0.00% | 11.51% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (0.12) | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.92 | 1.29 | 0.83 | 0.60 | 0.54 | 0.54 | 0.53 | 0.00 | 0.22 | 0.00 |
Capex/Depreciation |
0.00 | (5.92) | (2.90) | 0.00 | (30.43) | — | — | — | 0.00 | — |
Interest Coverage |
(1,328.30) | (249.82) | (983.92) | (1,931.23) | (264.94) | (31.18) | (318.29) | — | (34.21) | — |
| (373.18%) | (743.10%) | (4,408.46%) | (181.47%) | (160.92%) | (356.08%) | (774.81%) | 0.00% | 137.77% | 192.33% | |
| (262.55%) | (195.05%) | (303.88%) | (145.64%) | (141.86%) | (213.54%) | (266.08%) | (587.67%) | (323.97%) | (248.28%) | |
ROIC |
(24,352.22%) | (14,412.82%) | 0.00% | 0.00% | 0.00% | (738.82%) | (378.06%) | (2,096,687.50%) | (1,141.29%) | (1,141.27%) |
Return on Tangible Assets |
(1,196.45%) | (128.65%) | 383.44% | (488.53%) | (92.59%) | (250.70%) | (536.72%) | 0.00% | (1,534.40%) | (1,534.40%) |
Average Days of Receivables |
— | — | — | — | — | 0.00 | 0.00 | — | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | — |
Free Cash Flow per Share |
(2.42) | (15.24) | (113.44) | (123.59) | (101.83) | (50.41) | (44.43) | — | (23.97) | — |
Cash per Share |
0.21 | 8.76 | 5.07 | 71.20 | 213.09 | 35.86 | 1.71 | — | 0.98 | 0.00 |
Shareholders Equity per Share |
0.22 | 8.80 | (34.96) | 42.18 | 202.30 | 37.41 | 15.56 | 0.00 | 7.27 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Book value per Share |
0.22 | 8.80 | (34.96) | 42.18 | 202.30 | 37.41 | 15.56 | 0.00 | 7.27 | 0.00 |
Free Cash Flow |
(8.07) | (6.87) | (8.42) | (8.92) | (6.72) | (2.71) | (2.35) | — | (1.05) | — |
Working Capital |
0.42 | 3.54 | (2.77) | 2.97 | 13.25 | 2.01 | 0.82 | — | 0.32 | 0.32 |
Capital Expenditures |
— | (0.30) | (0.15) | — | (0.11) | — | — | — | — | — |
Net Current Asset Value |
0.42 | 3.54 | (2.77) | 2.97 | 13.25 | 2.01 | 0.82 | — | 0.32 | 0.32 |
| Other line items | ||||||||||
Quick Ratio |
0.53 | 6.22 | 0.12 | 1.79 | 12.07 | 2.14 | 0.09 | — | 0.04 | 0.04 |
Depreciation/Fixed assets |
0.35 | 0.12 | 0.29 | 0.29 | 0.03 | — | — | — | 0.00 | — |
Cash ROIC |
(558.75%) | (86.75%) | 438.97% | (109.00%) | (24.51%) | (63.40%) | (257.21%) | 0.00% | (290.74%) | 0.00% |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 0.00 | — | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Operating CF per Share |
(2.42) | (14.57) | (111.46) | (123.59) | (100.21) | (50.41) | (44.43) | — | (23.97) | — |
Capex per Share |
0.00 | (0.67) | (1.98) | 0.00 | (1.61) | 0.00 | 0.00 | — | 0.00 | — |
Average Receivables |
— | — | — | — | — | 0.11 | 0.24 | — | 0.35 | — |
Average Payables |
0.99 | 1.78 | 2.90 | 2.02 | 0.83 | 0.72 | 1.02 | — | 1.02 | — |
Average Assets |
3.34 | 2.62 | 3.27 | 10.22 | 8.71 | 2.36 | 1.66 | 0.75 | 1.50 | 1.96 |
Average Common Equity |
2.35 | 0.69 | 0.23 | 8.20 | 7.68 | 1.42 | 0.57 | — | (3.53) | (2.53) |
Capex to Sales |
— | 0.00 | 0.00 | — | 0.00 | — | — | — | — | — |
Columns are period end dates